• Home
  • Resources
  • Case Studies
  • About Us
  • Contact
Beyond Vital Signs Beyond Vital Signs Beyond Vital Signs Beyond Vital Signs
  • Home
  • Resources
  • Case Studies
  • About Us
  • Contact

Archives

Monthly Archive for: "March, 2021"
Home /
By Fifth Eye
In News
Posted March 9, 2021

FDA grants De Novo classification for innovative analytic technology developed at MCIRCC

Source: MCIRCC Michigan Medicine spin-off company, Fifth Eye, is launching their first product, the Analytic for Hemodynamic Instability (AHI). Read the full article >  

READ MORE
By Fifth Eye
In News
Posted March 2, 2021

FDA grants De Novo classification to Fifth Eye’s continuous hemodynamic status monitoring tool

Source: MobiHealthNews The Analytic for Hemodynamic Instability tool can identify hemodynamic instability with 96% sensitivity and detects stable patients with 85% specificity. Read the full [...]

READ MORE
By Fifth Eye
In News
Posted March 2, 2021

FDA Grants De Novo to ML-based, Real-time Indicator of Patient Deterioration

Source: Fifth Eye Inc. Fifth Eye’s noninvasive tool is the first to provide continuous monitoring of hemodynamic status using a single ECG lead Read the full press release >  

READ MORE

Fifth Eye

110 Miller Avenue, Suite 300
Ann Arbor, MI 48104

 

Explore
Home
Resources
Case Studies
About Us
Contact
Career
© 2021 FIFTH EYE INC. ALL RIGHTS RESERVED. | AHI INDICATIONS FOR USE